Literature DB >> 30174910

Lung transplantation: indications and contraindications.

David Weill1.   

Abstract

The selection of appropriate recipients for lung transplantation is an evolving discipline. As experience with the procedure has developed over the last decades, the identification of transplant candidates has also changed as transplant centers strive to safely provide the therapy to as many patients possible. The International Society for Heart and Lung Transplantation (ISHLT) has developed three editions of recipient selection guidelines. Published in 1998, 2006, and 2015, these guidelines represented the best information relevant to the appropriate selection of lung transplant candidates. A discussion of areas supported by the most robust scientific data will be undertaken, but in many aspects of recipient selection, there is a paucity of data upon which to rely. Therefore, it is ultimately the prerogative and responsibility of individual centers to determine, after carefully weighing the best evidence available, whether a patient is deemed a suitable candidate at a specific program. All possible indications and contraindications for transplantation will be reviewed with attention also given to the appropriate timing of referral and listing of patients with advanced lung disease to a transplant center.

Entities:  

Keywords:  Interstitial lung disease (ILD); chronic obstructive pulmonary disease (COPD); cystic fibrosis (CF); pulmonary arterial hypertension

Year:  2018        PMID: 30174910      PMCID: PMC6105990          DOI: 10.21037/jtd.2018.06.141

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  93 in total

1.  Systemic sclerosis and bilateral lung transplantation: a single centre experience.

Authors:  R Saggar; D Khanna; D E Furst; J A Belperio; G S Park; S S Weigt; B Kubak; A Ardehali; A Derhovanessian; P J Clements; S Shapiro; C Hunter; A Gregson; M C Fishbein; J P Lynch Iii; D J Ross; R Saggar
Journal:  Eur Respir J       Date:  2010-03-29       Impact factor: 16.671

Review 2.  Lung allocation in the United States.

Authors:  Michael Eberlein; Edward R Garrity; Jonathan B Orens
Journal:  Clin Chest Med       Date:  2011-06       Impact factor: 2.878

3.  Cystic fibrosis pulmonary guidelines: pulmonary complications: hemoptysis and pneumothorax.

Authors:  Patrick A Flume; Peter J Mogayzel; Karen A Robinson; Randall L Rosenblatt; Lynne Quittell; Bruce C Marshall
Journal:  Am J Respir Crit Care Med       Date:  2010-08-01       Impact factor: 21.405

4.  Previous intrapleural procedures do not adversely affect lung transplantation.

Authors:  M Dusmet; T L Winton; S Kesten; J Maurer
Journal:  J Heart Lung Transplant       Date:  1996-03       Impact factor: 10.247

5.  Recurrence of bronchioloalveolar carcinoma in donor lung after lung transplantation: microsatellite analysis demonstrates a recipient origin.

Authors:  J Javier Gómez-Román; Clara Esparza Del Valle; M Teresa Zarrabeitia; José Cifrián Martínez; Felipe Zurbano Goñi; Roberto Mons Lera; Jorge Cuevas; J Fernando Val-Bernal
Journal:  Pathol Int       Date:  2005-09       Impact factor: 2.534

6.  Outcomes in systemic sclerosis-related lung disease after lung transplantation.

Authors:  Peter D Sottile; David Iturbe; Tamiko R Katsumoto; M Kari Connolly; Harold R Collard; Lorriana A Leard; Steven Hays; Jeffrey A Golden; Charles Hoopes; Jasleen Kukreja; Jonathan P Singer
Journal:  Transplantation       Date:  2013-04-15       Impact factor: 4.939

7.  Pulmonary retransplantation: predictors of graft function and survival in 230 patients. Pulmonary Retransplant Registry.

Authors:  R J Novick; L W Stitt; K Al-Kattan; W Klepetko; H J Schäfers; J P Duchatelle; A Khaghani; R L Hardesty; G A Patterson; M H Yacoub
Journal:  Ann Thorac Surg       Date:  1998-01       Impact factor: 4.330

8.  Liver and combined lung and liver transplantation for cystic fibrosis: analysis of the UNOS database.

Authors:  Ronen Arnon; Rachel A Annunziato; Tamir Miloh; Maria Padilla; Hiroshi Sogawa; Linda Batemarco; Asha Willis; Frederick Suchy; Nanda Kerkar
Journal:  Pediatr Transplant       Date:  2011-01-10

9.  The influence of continuous intravenous prostacyclin therapy for primary pulmonary hypertension on the timing and outcome of transplantation.

Authors:  J V Conte; S P Gaine; J B Orens; T Harris; L J Rubin
Journal:  J Heart Lung Transplant       Date:  1998-07       Impact factor: 10.247

10.  A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.

Authors:  Talmadge E King; Williamson Z Bradford; Socorro Castro-Bernardini; Elizabeth A Fagan; Ian Glaspole; Marilyn K Glassberg; Eduard Gorina; Peter M Hopkins; David Kardatzke; Lisa Lancaster; David J Lederer; Steven D Nathan; Carlos A Pereira; Steven A Sahn; Robert Sussman; Jeffrey J Swigris; Paul W Noble
Journal:  N Engl J Med       Date:  2014-05-18       Impact factor: 91.245

View more
  15 in total

1.  Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation.

Authors:  Lorriana E Leard; Are M Holm; Maryam Valapour; Allan R Glanville; Sandeep Attawar; Meghan Aversa; Silvia V Campos; Lillian M Christon; Marcelo Cypel; Göran Dellgren; Matthew G Hartwig; Siddhartha G Kapnadak; Nicholas A Kolaitis; Robert M Kotloff; Caroline M Patterson; Oksana A Shlobin; Patrick J Smith; Amparo Solé; Melinda Solomon; David Weill; Marlies S Wijsenbeek; Brigitte W M Willemse; Selim M Arcasoy; Kathleen J Ramos
Journal:  J Heart Lung Transplant       Date:  2021-07-24       Impact factor: 13.569

2.  Prognostic impact of preoperative respiratory colonization on early-onset pneumonia after lung transplantation.

Authors:  Taehwa Kim; Hye Ju Yeo; Jin Ho Jang; Dohyung Kim; Doosoo Jeon; Yun Seong Kim; Woo Hyun Cho
Journal:  J Thorac Dis       Date:  2022-06       Impact factor: 3.005

3.  A Framework for Using Real-World Data and Health Outcomes Modeling to Evaluate Machine Learning-Based Risk Prediction Models.

Authors:  Patricia J Rodriguez; David L Veenstra; Patrick J Heagerty; Christopher H Goss; Kathleen J Ramos; Aasthaa Bansal
Journal:  Value Health       Date:  2021-12-22       Impact factor: 5.101

4.  Evaluation of Antimicrobial Susceptibility Testing Methods for Burkholderia cenocepacia and Burkholderia multivorans Isolates from Cystic Fibrosis Patients.

Authors:  Holly K Huse; Mark J Lee; Mandy Wootton; Susan E Sharp; Maria Traczewski; John J LiPuma; Peter Jorth
Journal:  J Clin Microbiol       Date:  2021-09-15       Impact factor: 5.948

5.  High prevalence of falsely declaring nicotine abstinence in lung transplant candidates.

Authors:  Tobias Veit; Dieter Munker; Gabriela Leuschner; Carlo Mümmler; Alma Sisic; Teresa Kauke; Christian Schneider; Michael Irlbeck; Sebastian Michel; Daniela Eser-Valerie; Maximilian Huber; Jürgen Barton; Katrin Milger; Bruno Meiser; Jürgen Behr; Nikolaus Kneidinger
Journal:  PLoS One       Date:  2020-06-18       Impact factor: 3.240

6.  Bilateral lung transplantation in cystic fibrosis with hepatitis C infection - a study of two cases.

Authors:  Nikola Ruszel; Bartosz Kubisa; Piotr Lisowski; Maria Piotrowska; Michał J Kubisa; Mirosław Brykczyński; Małgorzata Wojtyś; Jarosław Pieróg; Michalina Czarnecka; Janusz Wójcik; Norbert Wójcik; Piotr Sielicki; Michał Bielewicz; Tomasz Grodzki
Journal:  Kardiochir Torakochirurgia Pol       Date:  2019-10-28

Review 7.  Postoperative Management of Hyperinflated Native Lung in Single-Lung Transplant Recipients with Chronic Obstructive Pulmonary Disease: A Review Article.

Authors:  Islam M Shehata; Amir Elhassan; Ivan Urits; Omar Viswanath; Leonardo Seoane; Courtney Shappley; Alan D Kaye
Journal:  Pulm Ther       Date:  2020-12-02

8.  The impact of the COVID-19 pandemic on cardiac surgery and transplant services in Ireland's National Centre.

Authors:  Laura Casey; Niall Khan; David G Healy
Journal:  Ir J Med Sci       Date:  2020-07-04       Impact factor: 1.568

Review 9.  Lung transplantation: a review of the optimal strategies for referral and patient selection.

Authors:  Alicia B Mitchell; Allan R Glanville
Journal:  Ther Adv Respir Dis       Date:  2019 Jan-Dec       Impact factor: 4.031

10.  Evaluation of Three Culture Media for Isolation of Burkholderia cepacia Complex from Respiratory Samples of Patients with Cystic Fibrosis.

Authors:  Emma C L Marrs; Audrey Perry; John D Perry
Journal:  Microorganisms       Date:  2021-12-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.